HIV Remains Suppressed in Some Patients After Treatment Withdrawal
Scientists at Gladstone Institutes identified two host genes, DDIT4 and ZNF254, that act as molecular locks keeping HIV dormant after antiretroviral therapy (ART) cessation. Multi‑omic analysis of 75 participants from analytical treatment interruption trials linked higher expression of these genes, as well as stem‑cell memory CD8+ T cells and atypical NK cells, to delayed viral rebound. The common diabetes drug metformin was shown to induce DDIT4, blocking HIV reactivation in vitro, suggesting a low‑cost, repurposable pathway toward ART‑free remission. The team plans preclinical and clinical studies to test metformin’s therapeutic potential.
Skin Regeneration Enabled by Embryonic Healing Mechanism in Mice
Harvard researchers published a Cell study showing that mouse skin can fully regenerate by reactivating an embryonic healing program that normally shuts down after birth. They identified excessive nerve growth—hyperinnervation—driven by fibroblast‑derived Cxcl12 as the key barrier to regeneration. Genetic...
LazySlide: Open Framework for Integrating Whole-Slide and Molecular Data
LazySlide is an open‑source Python package built on the scverse ecosystem that streamlines whole‑slide image analysis and multimodal integration. It partitions massive pathology slides into manageable patches, applies foundation AI models to extract visual features, and directly links those features...
Targeting Tunneling Nanotubes Reduces Spread of Mutant Huntington’s Protein
Researchers at Florida Atlantic University discovered that the protein Rhes teams up with the bicarbonate transporter SLC4A7 to build tunneling nanotubes (TNTs) that ferry mutant huntingtin (mHTT) between neurons. Disrupting this Rhes‑SLC4A7 axis in mice dramatically curbed intercellular spread of...
Metastasis Slowed by Targeting Lipid Metabolism in Healthy Lung Cells
Researchers at VIB‑KU Leuven and the Francis Crick Institute discovered that alveolar type II (AT2) cells in the lung are reprogrammed by metastatic breast cancer to overproduce lipids, creating a nutrient‑rich niche that fuels tumor growth. The study showed that...
Modifying T Cell Receptor Improves Targeted Cancer Therapy
Researchers from UCLA, Stanford, Utah, and Columbia have engineered T cell receptors to strengthen catch‑bond interactions with prostate cancer antigens, improving cytotoxic function. By altering just one or two amino acids in the TCR, the modified cells exhibit longer bond...
Bio-Sourcing and Tiny Cargo Partner on Orally Delivered mAbs Using Goat Milk Exosomes
Bio‑Sourcing and The Tiny Cargo Company announced a strategic collaboration to co‑develop orally delivered monoclonal antibody therapies using goat‑milk‑derived exosomes. The partnership merges Bio‑Sourcing’s BioMilk platform, which produces high‑yield antibodies and milk extracellular vesicles in transgenic goats, with Tiny Cargo’s...
Baylor College of Medicine Taps Nautilus’ Voyager for Cancer Proteomics
Nautilus Biotechnology has enrolled Baylor College of Medicine as the first participant in its Voyager early‑access program, granting the school access to a single‑molecule proteomics platform capable of mapping up to 10 billion intact proteins per run. The collaboration, funded by...
After Buying HUB and Partnering with Promega, MilliporeSigma Charts Growth Path in Organoids
MilliporeSigma, the life‑science arm of Merck KGaA, completed its €104 million acquisition of HUB Organoids and has since integrated the business into its Discovery Solutions unit. The company launched a partnership with Promega to develop real‑time reporter assays for organoids, while...
EXoZymes’ Cell-Free Biomanufacturing Platform Gets Positive Feedback From Cayman Chemical
eXoZymes’ cell‑free biomanufacturing platform was independently run by Cayman Chemical at pilot scale, moving from a 1‑L test to a 100‑L reactor. The process produced over 500 g of pharma‑grade N‑trans‑caffeoyltyramine (NCT) with 99.6 % purity and maintained >99 % conversion despite pH...
HDX-MS Plus Computational Methods Provide Novel Approach to Study of Protein-Protein Interactions
Regeneron scientists have integrated hydrogen‑deuterium exchange mass spectrometry (HDX‑MS) with AI‑driven computational analysis to pinpoint binding sites, geometry, and stoichiometry in sandwich ELISA assays. The approach rapidly distinguishes protected versus exposed regions of antibodies, boosting assay specificity and sensitivity. By...
Electrorheoimaging Helps Manage Droplet Viscosity in Real-Time
Researchers at the University of Guelph introduced electrorheoimaging (ERI), a technique that merges electric‑field forcing, rheological measurement, and microscopic imaging to monitor droplet viscosity in real time. By adjusting the frequency of an applied electric field, they achieved instantaneous, reversible...
Benchtop Bioreactor Simplifies Macrophage Manufacturing
Scientists at Hannover Medical School have introduced a standardized protocol that generates macrophages from induced pluripotent stem cells using a 10‑50 mL benchtop bioreactor. The 24‑day workflow produces tens of millions of cells per harvest and allows multiple collections from a...
CAR T Production Bottlenecks Best Tackled with AI, Automation, and Skilled Staff
Patient‑specific CAR‑T therapies face a global production bottleneck due to centralized facilities, manual processes, and high variability in patient cell quality. Researchers highlight that decentralizing manufacturing, eliminating cryopreservation, and accelerating in‑process monitoring can cut vein‑to‑vein times. Automation and artificial intelligence...
Vitamin B2 Pathway Identified as Potential Target for Cancer Therapy
A CRISPR‑Cas9 screen revealed that riboflavin (vitamin B2) sustains the ferroptosis suppressor protein FSP1, shielding cancer cells from iron‑driven lipid peroxidation. Depleting vitamin B2 destabilizes FSP1 and renders tumor cells highly susceptible to ferroptosis. The researchers demonstrated that roseoflavin, a bacterial analog...
Bacteria 4D Simulation, Safer Large Gene Insertion, uniQure Roller Coaster
The J. Craig Venter Institute unveiled a 4D, nanoscale simulation that tracks the entire life cycle of a minimal bacterial cell, marking a milestone for synthetic biology. A new gene‑editing platform designs DNA donors that dodge immune detection, enabling safer,...
High Altitude Survival Gene Mutation Points to Strategy for Repairing Nerve Damage
Researchers identified a high‑altitude Retsat Q247R mutation that enhances myelin formation under hypoxic stress and accelerates remyelination in mouse models. The variant boosts neuronal production of the vitamin‑A‑derived metabolite ATDR, which activates the RXR‑γ pathway in oligodendrocyte progenitors. Administering ATDR...
Targeted Protein Degradation Drives Deal Between Enodia Therapeutics and Kezar Life Sciences
Enodia Therapeutics has acquired the Sec61‑based discovery assets of clinical‑stage biotech Kezar Life Sciences, paying an upfront $1 million with the potential for up to $127 million in milestone payments and royalties. The deal integrates Kezar’s ten‑year preclinical dataset into Enodia’s selective...
Seeing the Brain in a Different Light
Researchers at Kyushu University have introduced SeeDB‑Live, an isotonic optical‑clearing medium based on bovine serum albumin that renders brain tissue transparent while preserving normal neuronal function. The solution, refined after screening nearly 100 compounds, enables three‑fold brighter fluorescence imaging in...
Brain Atlas Maps Epigenetic Changes Associated with Aging in Mice
Scientists at the Salk Institute released the most comprehensive single‑cell atlas of epigenetic aging in the mouse brain, profiling over 200,000 cells across eight regions and 36 cell types with methylation, chromatin conformation, and spatial transcriptomics. The map uncovers cell‑type...
Tailored Training Can Address Biopharma Skills Shortage
Ireland’s National Institute for Bioprocess Research and Training (NIBRT) reports a persistent global shortage of biopharma manufacturing talent, especially engineers skilled in digital bioprocessing, automation and AI. The gap spans cell culture, downstream processing, aseptic manufacturing and quality functions, with...
Agentic AI Swarms Degrade Decision-Making
New research on the organizational physics of multi‑agent AI reveals that AI swarms suffer the same structural inefficiencies as human middle managers. In manufacturing and biopharma contexts, coordinated agents tend to optimize internal compliance metrics rather than actual batch yield,...
New Chromatography Resin Developed for Secretory Antibodies
Researchers at BOKU University in Vienna have engineered a novel chromatography resin designed to capture secretory immunoglobulin A (IgA) at titers suitable for commercial manufacturing. The resin employs a reengineered bacterial surface ligand, analogous to Protein A, within a macropore...
Safer Large DNA Insertion Moves Genetic Medicine Toward Scalability
Researchers at Massachusetts General Hospital, in partnership with Full Circles Therapeutics, have introduced a circular single‑stranded DNA donor platform called INSTALL that enables kilobase‑scale gene insertion without triggering the cGAS immune sensor. The method combines a short double‑stranded DNA segment...
Lonza Expands Agreement to Manufacture Gene Therapy for Transfusion-Dependent Beta-Thalassemia
Lonza has broadened its agreement with Genetix Biotherapeutics to increase manufacturing capacity for ZYNTEGLO, the sole FDA‑approved gene therapy for transfusion‑dependent beta‑thalassemia. Production will continue at Lonza’s Houston, Texas, dedicated cell‑and‑gene therapy site, with provisions to scale up for future...
Boron Chemistry Breaks Protein Synthesis Barrier, May Aid Cancer Therapies
Researchers at ETH Zurich have introduced a boron‑based ligation strategy that overcomes the concentration barrier in chemical protein synthesis. By masking potassium acyltrifluoroborates (KATs) with chiral zwitterionic complexes, the team achieved efficient peptide coupling at micromolar levels, far lower than...
Playing Sound Waves to Cells Decreases Laryngeal Cancer Aggressiveness
An international team led by the Turku Bioscience Centre discovered that applying sound‑wave vibration to vocal‑fold cancer cells restores cellular movement and markedly reduces tumor aggressiveness. The mechanical stimulation lowered levels of the oncogenic protein YAP, both in cultured cells...
CDMO Neuland Labs Expects Commercial Production Facility to Be Operational by Summer
Neuland Laboratories announced that the first module of its new commercial peptide manufacturing facility will be operational by summer on its 17‑acre Bonthapally campus in India. The module adds 6,370 L of solid‑phase and liquid‑phase peptide synthesis capacity, ranging from 250 L...
Resident Macrophages Play a Role in Maintaining Murine Intraocular Pressure
Duke University researchers discovered that resident tissue macrophages (RTMs) are essential for maintaining intraocular pressure (IOP) in mice. Fluorescent tagging showed that selective removal of RTMs clogged the eye's outflow pathway, causing fluid buildup and elevated IOP, while depletion of...
GLP-1 Drugs Modulate Gene Expression via MED14 Phosphorylation
Stable GLP‑1 receptor agonists such as Exendin‑4 and Ozempic improve beta‑cell viability by modulating gene expression. Researchers at the Salk Institute discovered that these drugs induce phosphorylation of Med14, a core subunit of the Mediator transcription complex. Phosphorylated Med14 enables...
A Noble Pursuit: A Long-Time AI-in-Biotech Skeptic Takes Another Look
Tim Harris, a veteran biotech investor, revisits his skepticism about artificial intelligence in drug discovery, noting the surge of AI‑focused startups and sizable funding rounds. He outlines how AI is being applied to molecular dynamics, protein‑protein interaction prediction, and antibody...
Genome Editing for Biopharmaceutical Manufacturing
Chinese hamster ovary (CHO) cells remain the backbone of biopharmaceutical manufacturing, but traditional gene‑editing tools struggle with low knock‑in efficiency. Transposase‑based platforms such as Leap‑In and piggyBac now provide high‑efficiency, multi‑copy integration and can handle large DNA cargos up to...
Upping the Profiling of Chemical Exposures in the Omics Sciences
Panome Bio, a multi‑omics contract research organization, unveiled an exposomics service platform that pairs untargeted Discovery Exposomics with targeted quantification of priority chemicals. The Discovery workflow leverages the MassID™ engine and a 32,000‑compound database to profile environmental exposures without prior...
Degenerating Tanycytes Disrupt Tau Removal, Shaping Alzheimer’s Progression
Researchers from Kyoto University and INSERM identified tanycytes as a previously unknown conduit that clears tau protein from cerebrospinal fluid into the bloodstream. In rodent and cellular models, blocking vesicular transport in these cells dramatically slowed tau efflux and worsened...
Therapeutic mRNA Reverses Genetic Infertility in Male Mouse Model
Scientists delivered naked Cldn11 messenger RNA directly into the testes of genetically infertile male mice, restoring Sertoli cell function and enabling spermatogenesis. The treatment produced viable sperm that generated healthy offspring via in‑vitro fertilization, without permanent germline alteration. The approach...
HSV-1 Liquifies Cell Nuclei to Aid Replication
Researchers at NYU Langone Health discovered that herpes simplex virus 1 (HSV‑1) deploys its early protein ICP4 to partially liquefy the densely packed human cell nucleus. This fluidization creates a more permissive environment for viral replication compartments, accelerating virus production....
Cryo-EM Drug Discovery Center in Bay Area Opened by Thermo Fisher Scientific
Thermo Fisher Scientific has opened a Cryo‑Electron Microscopy Drug Discovery Center in South San Francisco, offering pharmaceutical and biotech firms direct, hands‑on access to cutting‑edge cryo‑EM instrumentation. The facility is designed to accelerate structural insight generation, enabling faster, more cost‑effective...
At CNBC Cures, Becky Quick Leads Clarion Call for Rare Disease Research
The CNBC Cures Summit opened with Becky Quick urging families and innovators to accelerate rare‑disease research. Speakers highlighted a widening gap between rapid scientific breakthroughs—gene therapies, AI‑driven diagnostics, and modular “nodal biology”—and an aging regulatory framework. Leaders from Biogen, the...
Omics in Orlando Day 2: A Video Report From AGBT
The AGBT Day 2 video recap features Julianna LeMieux and Kevin Davies highlighting the meeting’s headline announcements. Vizgen unveiled a spatial‑omics platform aimed at organoid research, while Illumina introduced the TruPath Genome product, formerly known as Constellation mapped reads. Bruker launched...
Mutant P53 Selective Reactivation Demonstrated in Advanced Solid Tumors
PMV Pharmaceuticals reported Phase I results of rezatapopt, a small‑molecule p53 reactivator, in 77 patients with advanced solid tumors carrying the TP53 Y220C mutation. The oral drug was generally well tolerated, with few dose‑limiting toxicities, allowing the selection of a...
Increasing Rice Yields with Gene-Informed Selective Breeding
An international team led by Oxford, Nanjing Agricultural University and the Chinese Academy of Sciences identified the rice gene OsWRI1a as a key regulator of growth under varying nitrogen levels. Over‑expressing a strong OsWRI1a allele increased root‑to‑shoot ratios and grain...
ADMET Predictions Get AI Boost, Federated Data Network Unites Pharma
Apheris has launched the ADMET Network, a federated learning platform that lets pharmaceutical companies jointly train ADMET prediction models without exposing raw data. Five founding members—Lundbeck, Orion Pharma, Recursion, Servier and an undisclosed partner—have each contributed roughly 80% of their...
Bridging the Translation Gap for Regenerative Tissues
Muvon Therapeutics, a clinical‑stage company developing regenerative muscle treatments, is confronting the translation gap between academic discovery and commercial manufacturing. The firm highlights three core hurdles: co‑developing evolving regulatory frameworks, automating novel manufacturing processes, and recruiting personnel with GMP expertise....
Autonomy and Accountability in Bioprocessing
Artificial intelligence is transitioning from offline analysis to active laboratory roles, yet bioprocess engineering faces unique biological and regulatory hurdles. A recent review advocates hybrid laboratories that blend AI‑driven automation for core tasks with human oversight for auxiliary processes. High‑throughput...
Samsung Joins CEPI Vaccine Network to Prepare for Next Pandemic
Samsung Biologics has joined the Coalition for Epidemic Preparedness Innovations (CEPI) Vaccine Manufacturing Facility Network, committing to develop a ready‑to‑activate recombinant protein vaccine platform. Backed by a $20 million budget, Samsung will pre‑agree manufacturing processes, run simulated outbreak drills, and prepare...
Fermenter-Extractor-Separator Mixes Uniformly and Is Gentle on Cells
Researchers at Iowa State University have unveiled a Taylor Vortex Fermenter‑Extractor‑Separator that combines fermentation, extraction and separation in a single unit. The concentric‑cylinder design creates Taylor vortices, delivering uniform mixing while minimizing cell damage. Higher mass‑transfer rates cut gas consumption,...
Processing and Interpreting Untargeted Metabolomics Data for Biomarker Discovery and Drug Development
Panome Bio has launched MassID™, a cloud‑based platform that streamlines the processing and interpretation of untargeted LC/MS metabolomics data. The system delivers an end‑to‑end pipeline that cleans, normalizes, and annotates raw spectra while assigning probability‑based confidence scores and global false...
New Protein-Like Polymers Target, Degrade “Undruggable” Proteins Driving Cancer
Researchers at Northwestern University have created HYDRACs, hybrid degrading copolymers that bind and eliminate traditionally "undruggable" oncogenic proteins such as MYC and KRAS. The polymers display target‑recognizing peptides on one side and degron motifs on the other, directing the proteins...
Beam Designs New Approach for Direct Correction of Mutations Causing PKU
Beam Therapeutics announced BEAM-304, a liver‑targeted base‑editing program aimed at correcting PAH gene mutations that cause phenylketonuria (PKU). The approach uses multiple mutation‑specific editors within a single clinical development pathway, initially focusing on the two most common U.S. variants that...
Drug-Controlled CAR T Cells May Enable Safer Immunotherapy
Researchers at EPFL have created a drug‑controlled CAR‑T platform called DROP‑CAR that can be turned off on demand with the FDA‑approved BCL‑2 inhibitor venetoclax. The system places a reversible protein‑protein interaction on the cell surface, causing the CAR to dissociate...
